HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption JF Scheid, JA Horwitz, Y Bar-On, EF Kreider, CL Lu, JCC Lorenzi, ... Nature 535 (7613), 556-560, 2016 | 478 | 2016 |
Combination therapy with anti-HIV-1 antibodies maintains viral suppression P Mendoza, H Gruell, L Nogueira, JA Pai, AL Butler, K Millard, ... Nature 561 (7724), 479-484, 2018 | 461 | 2018 |
Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice A Halper-Stromberg, CL Lu, F Klein, JA Horwitz, S Bournazos, L Nogueira, ... Cell 158 (5), 989-999, 2014 | 415 | 2014 |
Enhanced clearance of HIV-1–infected cells by broadly neutralizing antibodies against HIV-1 in vivo CL Lu, DK Murakowski, S Bournazos, T Schoofs, D Sarkar, ... Science 352 (6288), 1001-1004, 2016 | 360 | 2016 |
Non-neutralizing antibodies alter the course of HIV-1 infection in vivo JA Horwitz, Y Bar-On, CL Lu, D Fera, AAK Lockhart, JCC Lorenzi, ... Cell 170 (4), 637-648. e10, 2017 | 150 | 2017 |
Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods CL Lu, CY Liu, YT Huang, CH Liao, LJ Teng, JD Turnidge, PR Hsueh Antimicrobial agents and chemotherapy 55 (9), 4295-4301, 2011 | 138 | 2011 |
Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009 CC Lai, CY Wang, CC Chu, CK Tan, CL Lu, YC Lee, YT Huang, PI Lee, ... Journal of antimicrobial chemotherapy 66 (6), 1374-1382, 2011 | 129 | 2011 |
Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity J Niessl, AE Baxter, P Mendoza, M Jankovic, YZ Cohen, AL Butler, CL Lu, ... Nature medicine 26 (2), 222-227, 2020 | 120 | 2020 |
Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir C Gaebler, JCC Lorenzi, TY Oliveira, L Nogueira, V Ramos, CL Lu, JA Pai, ... Journal of Experimental Medicine 216 (10), 2253-2264, 2019 | 106 | 2019 |
Relationship between latent and rebound viruses in a clinical trial of anti–HIV-1 antibody 3BNC117 YZ Cohen, JCC Lorenzi, L Krassnig, JP Barton, L Burke, J Pai, CL Lu, ... Journal of Experimental Medicine 215 (9), 2311-2324, 2018 | 101 | 2018 |
Recent hepatitis C virus infections in HIV-infected patients in Taiwan: incidence and risk factors HY Sun, SY Chang, ZY Yang, CL Lu, H Wu, CC Yeh, WC Liu, CY Hsieh, ... Journal of clinical microbiology 50 (3), 781-787, 2012 | 92 | 2012 |
Relationship between intact HIV-1 proviruses in circulating CD4+ T cells and rebound viruses emerging during treatment interruption CL Lu, JA Pai, L Nogueira, P Mendoza, H Gruell, TY Oliveira, J Barton, ... Proceedings of the National Academy of Sciences 115 (48), E11341-E11348, 2018 | 73 | 2018 |
Metabolic syndrome among HIV-infected Taiwanese patients in the era of highly active antiretroviral therapy: prevalence and associated factors PY Wu, CC Hung, WC Liu, CY Hsieh, HY Sun, CL Lu, H Wu, KL Chien Journal of Antimicrobial Chemotherapy 67 (4), 1001-1009, 2012 | 73 | 2012 |
Characterization of intact proviruses in blood and lymph node from HIV-infected individuals undergoing analytical treatment interruption LK Vibholm, JCC Lorenzi, JA Pai, YZ Cohen, TY Oliveira, JP Barton, ... Journal of virology 93 (8), 10.1128/jvi. 01920-18, 2019 | 63 | 2019 |
Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan: implication of sequence type for prognosis CL Lu, YC Chuang, HC Chang, YC Chen, JT Wang, SC Chang Journal of Antimicrobial Chemotherapy 67 (9), 2243-2249, 2012 | 52 | 2012 |
Seroprevalence of hepatitis virus infection in men who have sex with men aged 18–40 years in Taiwan YT Tseng, HY Sun, SY Chang, CH Wu, WC Liu, PY Wu, CL Lu, CY Hsieh, ... Journal of the Formosan Medical Association 111 (8), 431-438, 2012 | 50 | 2012 |
Comparative effectiveness of two doses versus three doses of hepatitis A vaccine in human immunodeficiency virus–infected and‐uninfected men who have sex with men YT Tseng, SY Chang, WC Liu, HY Sun, CH Wu, PY Wu, CL Lu, CC Hung, ... Hepatology 57 (5), 1734-1741, 2013 | 47 | 2013 |
Severe and refractory Clostridium difficile infection successfully treated with tigecycline and metronidazole. CL Lu, CY Liu, CH Liao, YT Huang, HP Wang, PR Hsueh International journal of antimicrobial agents 35 (3), 311-312, 2010 | 44 | 2010 |
Trends of transmitted drug resistance of HIV-1 and its impact on treatment response to first-line antiretroviral therapy in Taiwan CC Lai, CC Hung, MY Chen, HY Sun, CL Lu, YT Tseng, SF Chang, YC Su, ... Journal of antimicrobial chemotherapy 67 (5), 1254-1260, 2012 | 36 | 2012 |
Correlation between antimicrobial consumption and resistance among Staphylococcus aureus and enterococci causing healthcare-associated infections at a … CC Lai, CY Wang, CC Chu, CK Tan, CL Lu, YL Lee, YT Huang, PI Lee, ... European journal of clinical microbiology & infectious diseases 30, 265-271, 2011 | 35 | 2011 |